Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral: Vanier Canada Graduate Scholarships

University of Toronto

$150,000.00

Dissecting the role of the mammalian target of rapamycin in the renal glomerular filtration barrier and tubular epithelium.

FY 2011-12

Summary
The mammalian target of rapamycin (mTOR) is a protein that is found in every mammalian cell and is central to the control of many cellular functions including metabolism, growth, and division and is essential to life. Given its multitude of functions, mTOR is tightly regulated and loss of this regulation leads to disease. Drugs that block the function of mTOR are important in the management of patients with solid organ transplants, cancer, diabetes, polycystic kidney disease and atherosclerosis among many other conditions. However, the therapeutic usefulness of these drugs is hampered by their toxicity to the kidney. In light of the rapidly expanding indications for mTOR inhibitors, it is important that we better understand the mechanism underlying this toxicity. We have developed a novel genetic mouse model that will allow us to remove mTOR completely from select cell populations in the kidney. Our aim is to use this mouse model to study the mechanism underlying the kidney injury associated with mTOR inhibition and investigate possible therapies. In addition, this work will contribute significantly to the existing knowledge of the complex molecular pathways involved in mTOR regulation. Finally, the success of our study and novelty of our mouse model will foster collaboration with other research groups to establish a link between mTOR and disease mechanisms in other organ systems. This will allow clinicians to better harness the potential of mTOR inhibitors for the management of patients.
Program
Doctoral: Vanier Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
247815
Name
Cina Davide P
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Dissecting the role of the mammalian target of rapamycin in the renal glomerular filtration barrier and tubular epithelium.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Autophagy; Mammalian Target Of Rapamycin; Proteinuria; Renal Injury; Transgenic Mice; Transplant
Abstract
The mammalian target of rapamycin (mTOR) is a protein that is found in every mammalian cell and is central to the control of many cellular functions including metabolism, growth, and division and is essential to life. Given its multitude of functions, mTOR is tightly regulated and loss of this regulation leads to disease. Drugs that block the function of mTOR are important in the management of patients with solid organ transplants, cancer, diabetes, polycystic kidney disease and atherosclerosis among many other conditions. However, the therapeutic usefulness of these drugs is hampered by their toxicity to the kidney. In light of the rapidly expanding indications for mTOR inhibitors, it is important that we better understand the mechanism underlying this toxicity. We have developed a novel genetic mouse model that will allow us to remove mTOR completely from select cell populations in the kidney. Our aim is to use this mouse model to study the mechanism underlying the kidney injury associated with mTOR inhibition and investigate possible therapies. In addition, this work will contribute significantly to the existing knowledge of the complex molecular pathways involved in mTOR regulation. Finally, the success of our study and novelty of our mouse model will foster collaboration with other research groups to establish a link between mTOR and disease mechanisms in other organ systems. This will allow clinicians to better harness the potential of mTOR inhibitors for the management of patients.
Competitiondate
201111
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Cina, Davide P
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~
University of Toronto - $150,000 Grant (2011-12) | Canada Spends